Back

A life-time perspective on the effects of an early invasive compared with a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome - the FRISC II 15 years follow-up

29 August 2016 (14:15 - 14:30)
Organised by:
Congress Presentation Part of: Clinical Trial Update Coronary artery disease Infarction acute phase non STEMI ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Lars Wallentin

Uppsala University, Uppsala (Sweden)

5 More presentations in this session

Presentation thumbnail
5-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents in unselected patients
Mr E. Christiansen (Aarhus, DK)
Slides Video
Presentation thumbnail
10-year follow-up of clinical outcomes in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.
Professor R. De Winter (Amsterdam, NL)
Slides Video
Presentation thumbnail
Comparative Efficacy of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Diabetic Patients with Multivessel Coronary Artery Disease With or Without Renal Dysfunction
Doctor U. Baber (New York, US)
Slides Video
Presentation thumbnail
The effect of CABG by age in patients with heart failure: 10 year follow data from the STICHES study
Professor E. Velazquez (New Haven, US)
Slides Video
Presentation thumbnail
ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions
Professor T. Kimura (Hirakata, JP)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Update Coronary artery disease

The Event

Event poster

ESC Congress 2016

29 August 2016 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources